Publications by authors named "D Rauh"

Claim this Profile
P
Phase II Trial of Ponatinib in Patients with Metastatic Gastrointestinal Stromal Tumor following Failure or Intolerance of Prior Therapy with Imatinib (POETIG Trial).
Johanna Falkenhorst, Philipp Ivanyi, Tom Schulz, Rainer Hamacher, Bernd Kasper, Daniel Rauh

Clin Cancer Res· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting KRAS with cyclic linker based inhibitors to explore warhead orientation.
Tonia Kirschner, João Rodriguez, Emerson Gonçalves Moreira, Janina Niggenaber, Jonas D Warmuth, Daniel Rauh

Sci Rep· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Computational Design of Lysine Targeting Covalent Binders Using Rosetta.
Barr Tivon, Jan Wiese, Matthias P Müller, Ronen Gabizon, Daniel Rauh

J Chem Inf Model· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advancing TET Inhibitor Development: From Structural Insights to Biological Evaluation.
Suzanne Willems, Lejla Maksumic, Janina Niggenaber, Tzu-Chen Lin, Tom Schulz, Daniel Rauh

ACS Med Chem Lett· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design, Synthesis, and SAR of Covalent KIT and PDGFRA Inhibitors─Exploring Their Potential in Targeting GIST.
Tom Schulz, Rajesh Gontla, Alina Teuber, Maria Beerbaum, Benjamin S Fletcher, Daniel Rauh

J Med Chem· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis